November 25, 2024 - 22:01

IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
April 20, 2026 - 19:27
Navigating the AI Regulatory Maze: Experts Weigh In on Innovation and PolicyThe rapid advancement of artificial intelligence has sparked a complex global debate on how best to govern the technology. According to analysts Anna Viñals Musquera and Scott Babwah Brennen, a...
April 20, 2026 - 10:07
New technology is increasing the speed and depth of cyber attacksFinancial services groups are having to adapt rapidly to a changing threat landscape, as new technology dramatically increases the speed and depth of cyber attacks. The industry, a perennial target...
April 19, 2026 - 18:00
Why were there fewer snow days this school year? It’s another aftereffect of the pandemic.The familiar ritual of waking up to a snow-covered world and the joyous announcement of a canceled school day is becoming increasingly rare. Across many districts, the traditional snow day has been...
April 19, 2026 - 07:31
Is It Too Late To Consider Align Technology (ALGN) After Recent Share Price Rebound?After a significant rebound, investors are questioning whether Align Technology`s stock still holds potential or if the window for substantial gains has closed. The company`s share price, now...